IMMUNOMODULATING O-HET-ARYL AZALIDES
Defined herein are immunomodulating Formula (1) compounds stereoisomers thereof, and pharmaceutically acceptable salts thereof; wherein R0, R1, R2, R10, W, Ring C and n are as defined herein, stereoisomers thereof, and pharmaceutically acceptable salts thereof; and compositions comprising said compo...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
15.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Defined herein are immunomodulating Formula (1) compounds stereoisomers thereof, and pharmaceutically acceptable salts thereof; wherein R0, R1, R2, R10, W, Ring C and n are as defined herein, stereoisomers thereof, and pharmaceutically acceptable salts thereof; and compositions comprising said compounds. The invention also includes methods for treating an inflammatory and/or immunological disease or disorder in an animal by administering a therapeutically effective amount of a Formula (1) compound, stereoisomer thereof, and a pharmaceutically acceptable salt thereof; or use of said compound of Formula (1) to prepare a medicament for treating an inflammatory and/or immunological disease or disorder in an animal.
En la presente se definen compuestos inmunomoduladores de la Fórmula (1) estereoisómeros de este y sales farmacéuticamente aceptables de este; en donde R0, R1, R2, R10, W, el anillo C y n son como se define en la presente, estereoisómeros de estos y sales farmacéuticamente aceptables de estos; y composiciones que comprenden dichos compuestos; la invención también incluye métodos para tratar una enfermedad o trastorno inflamatorio y/o inmunológico en un animal al administrar una cantidad terapéuticamente eficaz de un compuesto de la Fórmula (1), estereoisómero de este, y una sal farmacéuticamente aceptable de este; o el uso de dicho compuesto de la Fórmula (1) para preparar un medicamento para tratar una enfermedad o trastorno inflamatorio y/o inmunológico en un animal. |
---|---|
Bibliography: | Application Number: MX20220011242 |